Glick Anndee M
Mercy Safe Watch, St. John's Mercy Medical Center, St. Louis, MO, USA.
Nephrol Nurs J. 2007 Mar-Apr;34(2):176-82.
Focal segmental glomerulosclerosis is a form of chronic kidney disease that causes 3.6% of end stage renal disease cases. While the cause of this disease is multifactoral, the Human Genome Project has identified some specific chromosome sites linked to this disease process. Treatment for focal segmental glomerulosclerosis may include corticosteroids, managing hypertension, and controlling proteinuria. This article discusses the pathophysiology of focal segmental glomerulosclerosis, treatments, and resources for patient and professional education.
局灶节段性肾小球硬化是一种慢性肾病，占终末期肾病病例的3.6%。虽然这种疾病的病因是多因素的，但人类基因组计划已经确定了一些与该疾病进程相关的特定染色体位点。局灶节段性肾小球硬化的治疗可能包括使用皮质类固醇、控制高血压和控制蛋白尿。本文讨论了局灶节段性肾小球硬化的病理生理学、治疗方法以及患者和专业人员教育资源。
